Abstract:Background Current guidelines support primary percutaneous coronary intervention (primary PCI) as the first treatment of choice (as opposed to thrombolytic therapy) for patients with acute ST-segment elevation myocardial infarction (STEMI) especially when delivered within 12 hours of symptom onset. We aimed to evaluate the impact of different clinical pathways on reduction of reperfusion delay and subsequent improvement in outcomes in patients with STEMI.Methods From November 2005 to November 2007, 546 consecutive patients with definite STEMI, who upon arrival at the emergency room were triaged to undergo primary PCI, were included. Of them, 271 patients were brought directly to catheterization laboratory (rapid group), and 275 patients were admitted to the coronary care unit (CCU) or cardiac ward first, and then transferred to the catheterization laboratory (non-rapid group). Primary endpoint was door-to-balloon (D2B) time, and secondary endpoints included infarct size assessed by peak CK-MB level and rates of major cardiac adverse events (MACE) including death, reinfarction, or target-vessel revascularization during hospitalization and at 30-day clinical follow-up.Results Baseline clinical characteristics, angiographic features and procedural success rates were comparable between the two groups, except that more patients received glycoprotein IIb/IIIa receptor inhibitors before angiography (84.0% and 77.1, P=0.042) and had TIMI 3 flow in the culprit vessel at initial angiogram (17.1 % and 9.2%, P=0.007) in the non-rapid group. The D2B time was shortened ((108 +/- 44) minutes and (138 +/- 31) minutes, P <0.0001), and number of patients with D2B time <90 minutes was greater (22.6% and 10.9%, P <0.0001) in the rapid group. The advantages associated with rapid intra-hospital transfer were enhanced if the patients presented to the hospital at regular hours. Peak CK-MB level was significantly reduced in the rapid group. In-hospital mortality (4.1% and 5.8%) and cumulative MACE rate (7.0% and 9.8%) did not significantly differ between rapid and non-rapid groups. At 30 days, cumulative death- and MACE-free survival rates were improved in the rapid group (94.5% and 89.5%, P=0.035; 90.1% and 84.0%, P=0.034, respectively).Conclusions Clinical pathway with bypass of CCU/cardiac ward admission was associated with rapid reperfusion, smaller infarct size, and improved short-term survival for patients with STEMI undergoing primary PCI. In the future, it is essential to reduce the time delay for patients presenting at off-hours.

Impact of Different Emergency Treatment Methods on Prognosis of Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Retrospective Study

Impact of Different Treatment Times on Prognosis of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Influence of percutaneous coronary intervention timing on the prognosis of patients with acute ST segment elevation myocardial infarction

Impact of Different Clinical Pathways on Outcomes of Patients with Acute St-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: the Rapid-Ami Study

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Different Treatment Interventions Affect Plasma NT-ProBNP Levels and Early Exercise Tolerance in Patients with Acute ST-Segment Elevation Myocardial Infarction

The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study

Impact of Emergency Percutaneous Coronary Intervention on Outcomes of ST-segment Elevation Myocardial Infarction Patients Complicated by Out-of-hospital Cardiac Arrest.

Effect of different stent implantation time for percutaneous coronary intervention on efficacy and prognosis of acute ST-segment elevation myocardial infarction

Survival analysis on different treatment of acute myocardial infarction

Impact of different strategies of complete percutaneous revascularization on prognosis of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease

Optimization of Emergency Care Pathway Beginning with Pre-admission Procedures for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Impact on First Medical Contact to Balloon Time and Prognosis

Long-term Prognosis of Patients with Acute Non-St-segment Elevation Myocardial Infarction Undergoing Different Treatment Strategies.

Clinical assessment for the long-term benefits of delayed percutaneous transluminal coronary intervention in patients with acute myocardial infarction

Investigating the Efficacy of Pre-Hospital and In-Hospital Collaborative Treatment Platform Connected with 120-Ambulance in the Treatment of Patients with Acute Myocardial Infarction

The Impact of COVID-19 on Short-Term Prognosis of ST-segment Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention in Wuhan China

Emergency percutaneous coronary interventional in treatment of 35 cases of acute myocardial infarction

One-Year Clinical Outcome of Interventionalist- Versus Patient-Transfer Strategies for Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

Comparision of Short - Term Effect of Thrombolysis and Percutaneous Coronary Intervention on Acute Myocardial Infarction

Factors Influencing Late Prognosis In Patients With Acute St-Segment Elevation Myocardial Infarction Treated With Direct Percutaneous Coronary Intervention

Abstract 10840: Direct Admission versus Inter-Hospital Transfer of Hospitalized Patients with Acute Myocardial Infarction in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project